GEVO
Gevo, Inc.
NASDAQ · USBasic MaterialsChemicals - Specialty
$1.72+5.52%
Price as of Jul 20, 2026
GEVO financials
Gevo, Inc. financial statements
Annual and quarterly income statement, balance sheet and cash-flow history. On small screens, start with four periods and expand the table when needed.
| Metric | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue | $160.6M | $16.9M | $17.2M | $1.2M |
| Cost of revenue | $112.0M | $12.0M | $12.0M | $8.7M |
| Gross profit | $48.5M | $4.9M | $5.2M | -$7.5M |
| Operating expenses | $67.4M | $95.7M | $87.0M | $95.2M |
| Operating income | -$18.9M | -$90.8M | -$81.8M | -$102.7M |
| Net income | -$33.8M | -$78.6M | -$66.2M | -$98.0M |
| EBITDA | $10.3M | -$56.5M | -$45.0M | -$89.0M |
| Basic EPS | $-0.14 | $-0.34 | $-0.28 | $-0.44 |
| Diluted EPS | $-0.14 | $-0.34 | $-0.28 | $-0.44 |
| Balance sheet | ||||
| Cash & equivalents | $1.1M | $189.4M | $298.3M | $237.1M |
| Total assets | $718.9M | $583.9M | $650.3M | $700.7M |
| Total liabilities | $247.8M | $94.5M | $92.9M | $95.3M |
| Stockholders’ equity | $466.3M | $489.5M | $557.4M | $605.5M |
| Total debt | $167.5M | $70.6M | $70.2M | $69.7M |
| Net debt | $166.4M | -$118.8M | -$228.2M | -$167.4M |
| Cash flow | ||||
| Operating cash flow | -$13.4M | -$57.4M | -$53.7M | -$44.3M |
| Capital expenditure | -$30.1M | -$51.1M | -$54.5M | -$84.1M |
| Free cash flow | -$43.5M | -$108.5M | -$108.2M | -$128.4M |
| Dividends paid | $0.00 | $0.00 | $0.00 | $0.00 |
| Share repurchases | $0.00 | -$4.7M | $0.00 | $0.00 |